Compare AFG & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFG | ELAN |
|---|---|---|
| Founded | 1872 | 1954 |
| Country | United States | United States |
| Employees | 8500 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.7B |
| IPO Year | N/A | 2018 |
| Metric | AFG | ELAN |
|---|---|---|
| Price | $136.65 | $21.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $141.00 | $27.89 |
| AVG Volume (30 Days) | 373.3K | ★ 6.2M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | N/A | $8.21 |
| Revenue Next Year | $4.44 | $5.31 |
| P/E Ratio | ★ $12.86 | $192.45 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $121.18 | $12.90 |
| 52 Week High | $150.02 | $27.72 |
| Indicator | AFG | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 48.30 |
| Support Level | $127.48 | $21.22 |
| Resistance Level | $139.75 | $22.81 |
| Average True Range (ATR) | 2.44 | 1.37 |
| MACD | 0.46 | -0.06 |
| Stochastic Oscillator | 84.13 | 35.05 |
American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.